Gsa Capital Partners LLP Amphastar Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 17,434 shares of AMPH stock, worth $476,471. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,434
Previous 6,249
178.99%
Holding current value
$476,471
Previous $303,000
113.53%
% of portfolio
0.05%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$162 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$74.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$50.3 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$43.6 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$37.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.34B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...